Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study

OBJECTIVES: The long-term safety, tolerability, and efficacy of paliperidone extended-release (ER) were evaluated in Chinese patients with schizophrenia. METHODS: Patients (aged ≥18 years) with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, 4th edition criteria) who had comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongyan, Li, Huafang, Liu, Yanning, Wu, Cathy, Wu, Qingqi, Nuamah, Isaac, Shi, Jianguo, Xie, Shiping, Wang, Gang, Gopal, Srihari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712970/
https://www.ncbi.nlm.nih.gov/pubmed/26811679
http://dx.doi.org/10.2147/NDT.S88875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712970/
https://www.ncbi.nlm.nih.gov/pubmed/26811679
http://dx.doi.org/10.2147/NDT.S88875

Ejemplares similares